Skip to main content
. 2016 Nov 4;7(50):83231–83240. doi: 10.18632/oncotarget.13081

Figure 1. Comparison of microparticle and PDI activity in plasma.

Figure 1

A. Detection of endothelial microparticles (EMPs) and platelet derived microparticles (PMPs) by flow cytometry in plasma of the control group and MetS patients. B. Detection of plasma PDI activity by insulin transhydrogenase assay of the control group and MetS patients. C. Detection of PDI activity in plasma microparticles of the control group and MetS patients. *P<0.05 compared with the control. Data are from at least three separate experiments.